With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Screen to Intervene: A Family-Centered Approach to Identifying and Communicating Family Psychosocial Risk and Developing Evidence Based Clinical Pathways in Hematopoietic Stem Cell Transplantation||Alfred I duPont Hospital for Children / Anne Kazak, PhD||Psychosocial Grants||2015||Delaware|
|Using Chemical Genetics to Define the Precise Role of RUNX1 in Transcription and Beyond||Albert Einstein College of Medicine / Kristy Stengel||RUNX1 Early Career Investigator Grants||2022||New York|
|WIP1 Modulates Responsiveness of MB to Genotoxic Stress.||Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta / Robert Craig Castellino, MD||Young Investigator Grants||2006||Georgia|
|CHOA Experimental Therapy Pediatric Oncology Research.||Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta / Howard Katzenstein, MD||Phase I/II Infrastructure Grants||2006||Georgia|
|Expansion of the Innovative Therapies Program to Include the Development of a Pediatric Neuro-Oncology Translational Research Program||Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta / Howard Katzenstein, MD||Phase I/II Infrastructure Grants||2010||Georgia|
|Image Guided Diffuse Intrinsic Pontine Glioma Drug Delivery and Design||Weill Cornell Medical College / Mark Souweidane, MD & Richard Ting, PhD||Innovation Grants||2016||New York|
|Circulating Exosomes as Biomarkers of Medulloblastoma Progression, Metastasis, and Recurrence||Weill Cornell Medical College / David Lyden, MD/PhD & Parveen Raju, MD/PhD||Innovation Grants||2016||New York|
|Targeting the ALT Pathway to Induce Synthetic Lethality and Treat Poor Outcome Pediatric Tumors||University of California, Davis / Wolf-Dietrich Heyer, PhD||Innovation Grants||2018||California|
|Targeting Secondary Mutations in Juvenile Myelomonocytic Leukemia||University of California San Francisco / Elliot Stieglitz, MD||Young Investigator Grants||2015||California|
|Targeting inhibitory phosphatase signaling in high-risk childhood ALL||University of California San Francisco / Markus Muschen, MD, PhD||Innovation Grants||2011||California|